Abdel Halim | Vice President Translational Medicine, Biomarkers and Diagnostics
Celldex Therapeutics

Appearances:

Day One @ 11:20

Bridging the gap between translational and precision medicine

•     Focusing on potential precision medicine targets as early as phase I and II of clinical trials
•     Determining which targets are amenable to precision medicine in order to ensure a streamlined transition from pre-clinical to clinical research
•     Recruiting specific disciplinary talent for improved organizational structure